lobbying_activities: 2340187
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2340187 | 48b3c17c-ffc7-47d6-a37f-92e66f7ffacc | Q3 | CAPITOL HILL STRATEGIES, LLC | 91774 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2019 | third_quarter | MMM | Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals. Issues relating to biologics and biosimilars in Medicare and generally. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2019-10-10T16:06:21.397000-04:00 |